Biologicals

Papers
(The H4-Index of Biologicals is 10. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Animal testing for vaccines. Implementing replacement, reduction and refinement: challenges and priorities33
SARS-CoV-2 and the safety margins of cell-based biological medicinal products17
Next-generation vaccines and the impacts of state-of-the-art in-silico technologies17
Novel application of adipose-derived mesenchymal stem cells via producing antiangiogenic factor TSP-1 in lung metastatic melanoma animal model16
Analytical and functional similarity of biosimilar ABP 798 with rituximab reference product15
Integrating 3Rs approaches in WHO guidelines for the batch release testing of biologicals14
Anti-CD20 monoclonal antibodies in Systemic Lupus Erythematosus14
Recent progress and advances towards developing enterovirus 71 vaccines for effective protection against human hand, foot and mouth disease (HFMD)13
Establishment of a low-tumorigenic MDCK cell line and study of differential molecular networks11
Autogenous vaccines: Quality of production and movement in a common market10
0.028456926345825